| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GYRE THERAPEUTICS, INC. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 341,000 | 14 Aug 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS, INC. | 14 Aug 2024 | 1 | $0 | 4 | Chief Executive Officer, Director | 16 Aug 2024, 20:50 |
| GYRE | GYRE THERAPEUTICS, INC. | 31 Oct 2023 | 1 | $0 | 4 | Director | 01 Nov 2023, 06:15 |
| GYRE | GYRE THERAPEUTICS, INC. | 30 Oct 2023 | 0 | $0 | 3 | Director | 01 Nov 2023, 06:07 |